Literature DB >> 34055910

Psoriasis Exacerbation after Candida Antigen Immunotherapy Injection.

Sameh Magdy Sarsik1, Sarah Hamdy Soliman1.   

Abstract

BACKGROUND: Immunotherapy as wart treatment has been proposed as a successful and well-tolerated treatment option. However, as their action is not confined to the site of injection, the activation of the immune system in a way may alter the immune state of the patient. CASE
PRESENTATION: A case of 29-year-old patient who experienced psoriasis exacerbation and psoriatic arthritis within days following Candida antigen immunotherapy injection for resistant filiform wart management.
CONCLUSION: Candida antigen injection may cause psoriasis exacerbation, as TNFα and subsequent T-helper 1 induction is crossroad in both psoriasis and Candida antigen immunotherapy. Therefore, we report this case to state that besides the effectiveness of Candida antigen for wart therapy, caution should be considered if used in patients who are susceptible to psoriasis with meticulous follow-up or better to apply an alternative treatment option.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Candida antigen; Immunotherapy; Nail psoriasis; Psoriasis; Wart

Year:  2021        PMID: 34055910      PMCID: PMC8138216          DOI: 10.1159/000512568

Source DB:  PubMed          Journal:  Skin Appendage Disord        ISSN: 2296-9160


  12 in total

1.  Phase 1 clinical trial of intralesional injection of Candida antigen for the treatment of warts.

Authors:  Kevin H Kim; Thomas D Horn; Joni Pharis; Jay Kincannon; Robert Jones; Kevin O'Bryan; Jennifer Myers; Mayumi Nakagawa
Journal:  Arch Dermatol       Date:  2010-12

Review 2.  Intralesional antigen immunotherapy for the treatment of warts: current concepts and future prospects.

Authors:  Ahmad Nofal; Eman Salah; Eman Nofal; Ayman Yosef
Journal:  Am J Clin Dermatol       Date:  2013-08       Impact factor: 7.403

Review 3.  Intralesional immunotherapy for the treatment of warts: A network meta-analysis.

Authors:  Samar Salman; Mohamed Shehata Ahmed; Ahmed Mohamed Ibrahim; Omar Mohamed Mattar; Hassan El-Shirbiny; Sameh Sarsik; Ahmed M Afifi; Ruba Marwan Anis; Nadim Aiman Yakoub Agha; Abdelrahman Ibrahim Abushouk
Journal:  J Am Acad Dermatol       Date:  2018-07-10       Impact factor: 11.527

4.  The painful purple digit: an alarming complication of Candida albicans antigen treatment of recalcitrant warts.

Authors:  Marissa Perman; J Barton Sterling; Anthony Gaspari
Journal:  Dermatitis       Date:  2005-03       Impact factor: 4.845

5.  Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial.

Authors:  Thomas D Horn; Sandra M Johnson; Ricki M Helm; Paula K Roberson
Journal:  Arch Dermatol       Date:  2005-05

6.  Candida skin test reagent as a novel adjuvant for a human papillomavirus peptide-based therapeutic vaccine.

Authors:  Xuelian Wang; Hannah N Coleman; Uma Nagarajan; Horace J Spencer; Mayumi Nakagawa
Journal:  Vaccine       Date:  2013-10-14       Impact factor: 3.641

7.  Uveitis Following Treatment of Verruca Vulgaris with Intralesional Candida Antigen.

Authors:  Nicholas J Crowley; John C Hagan; Jonathan A Dyer; Tyler F Brundige
Journal:  Mo Med       Date:  2017 Sep-Oct

Review 8.  A comprehensive review of biomarkers in psoriasis.

Authors:  R Rashmi; K S J Rao; K H Basavaraj
Journal:  Clin Exp Dermatol       Date:  2009-06-25       Impact factor: 3.470

Review 9.  New insight into the pathogenesis of nail psoriasis and overview of treatment strategies.

Authors:  Alessandra Ventura; Mauro Mazzeo; Roberta Gaziano; Marco Galluzzo; Luca Bianchi; Elena Campione
Journal:  Drug Des Devel Ther       Date:  2017-08-30       Impact factor: 4.162

10.  An aberrant reaction to Candida albicans antigen used for recalcitrant warts successfully treated with oral prednisone.

Authors:  Andrew La'Pelusa; Jennifer Rorex; Nathan M Weir; Jeffrey Bryant Travers
Journal:  JAAD Case Rep       Date:  2018-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.